Sex: M
Vaccine: RAB
Symptoms: Inappropriate schedule of product administration
Clinical narrative: The patient received first dose of RabAvert four days after exposure and did not receive the second dose on scheduled date; Case reference number US-BN-2024-002668 is a spontaneous case initially received from a physician via Med Communications (reference number: USBAV24-2780) on 21-Oct-2024 and concerns a male patient of unknown age.  The patient's medical history and concomitant medication details were not provided.  The patient's past vaccination included unspecified rabies vaccine.  On night of 12-Oct-2024 to 13-Oct-2024, as reported the patient could hear and see bats flying around but never touched the patient.  On 17-Oct-2024, four days after bat encounter, the patient was vaccinated with the first dose of RabAvert (batch number: unknown) at an unknown dose, route and site of administration for post exposure (explicitly coded as 'inappropriate schedule of vaccine administered').  As reported, patient was scheduled to get second dose yesterday but was worried about the risk of getting Creutzfeldt-Jakob disease (CJD) and didn't go to take the dose, patient asked if the low-risk exposure justifies the risk of getting CJD and requested probability of the risk of getting CJD (explicitly coded as 'inappropriate schedule of vaccine administered').  At the time of the initial report, it was unknown if the patient experienced any adverse events due to RabAvert.  No further information was provided.; Reporter's Comments: A male patient of unknown age was vaccinated with the first dose of RabAvert four days after a bat encounter for post exposure, which is considered as inappropriate schedule of vaccine administered. As reported, the patient was scheduled to get second dose but was worried about the risk of getting Creutzfeldt-Jakob disease (CJD) and didn't go to take the dose, which is as inappropriate schedule of vaccine administered. It was unknown if the patient experienced any adverse events due to RabAvert. Inappropriate schedule of product administration is considered as listed per company convention. The patient's medical history and concomitant medication details were not provided, and past vaccination included unspecified rabies vaccine. Inappropriate schedule of product administration is not related to the suspect vaccine, but to a human factor. This case is considered as non-serious.; Sender's Comments: A male patient of unknown age was vaccinated with the first dose of RabAvert four days after a bat encounter for post exposure, which is considered as inappropriate schedule of vaccine administered. As reported, the patient was scheduled to get second dose but was worried about the risk of getting Creutzfeldt-Jakob disease (CJD) and didn't go to take the dose, which is as inappropriate schedule of vaccine administered. It was unknown if the patient experienced any adverse events due to RabAvert. Inappropriate schedule of product administration is considered as listed per company convention. The patient's medical history and concomitant medication details were not provided, and past vaccination included unspecified rabies vaccine. Inappropriate schedule of product administration is not related to the suspect vaccine, but to a human factor. This case is considered as non-serious.